---
title: "Real-world data show Cook’s Zilver PTX leads to lower rates of in-stent occlusion than Boston Scientific’s Eluvia"
date: "2025-03-27T13:05:41.000Z"
publishedDate: "27 mars 2025"
summary: "Cook Medical has announced that its Zilver PTX drug-eluting stent (DES) has lower rates of in-stent occlusions among patients with restenosis at three years than the Eluvia DES (Boston Scientific), according to real-world data from the REALDES study. The company notes that the data, published by Tsuyoshi Shibata (Sapporo Medical University Hospital, Sapporo, Japan) et al in the European Journal of Vascular and Endovascular [&#8230;] The post Real-world data show Cook’s Zilver PTX leads to lower rates of in-stent occlusion than Boston Scientific’s Eluvia appeared first on Vascular News ."
importance: ""
sourceUrl: "https://vascularnews.com/real-world-data-show-cooks-zilver-ptx-leads-to-lower-rates-of-in-stent-occlusion-than-boston-scientifics-eluvia/"
tags: ["France", "Actualité", "Vascular News — Latest"]
permalink: "/papers/2025-03-27-real-world-data-show-cooks-zilver-ptx-leads-to-lower-rates-of-in-stent-occlusion-than-boston-scientifics-eluvia"
imageUrl: "https://vascularnews.com/wp-content/uploads/sites/7/2025/03/Zilver-PTX-image-from-Peter.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://vascularnews.com/real-world-data-show-cooks-zilver-ptx-leads-to-lower-rates-of-in-stent-occlusion-than-boston-scientifics-eluvia/"
---

![Real-world data show Cook’s Zilver PTX leads to lower rates of in-stent occlusion than Boston Scientific’s Eluvia](https://vascularnews.com/wp-content/uploads/sites/7/2025/03/Zilver-PTX-image-from-Peter.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://vascularnews.com/real-world-data-show-cooks-zilver-ptx-leads-to-lower-rates-of-in-stent-occlusion-than-boston-scientifics-eluvia/*

## L’essentiel

Cook Medical has announced that its Zilver PTX drug-eluting stent (DES) has lower rates of in-stent occlusions among patients with restenosis at three years than the Eluvia DES (Boston Scientific), according to real-world data from the REALDES study. The company notes that the data, published by Tsuyoshi Shibata (Sapporo Medical University Hospital, Sapporo, Japan) et al in the European Journal of Vascular and Endovascular [&#8230;] The post Real-world data show Cook’s Zilver PTX leads to lower rates of in-stent occlusion than Boston Scientific’s Eluvia appeared first on Vascular News .

## Lien source

https://vascularnews.com/real-world-data-show-cooks-zilver-ptx-leads-to-lower-rates-of-in-stent-occlusion-than-boston-scientifics-eluvia/
